Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT05689541 · ClinicalTrials.gov registry record · NA

Development of a Parent-mediated Mobile App Intervention for Parents of Children With Autism Spectrum Disorder Participating in an Adapted Horseback Riding Program

A NA study, sponsored by University of Wisconsin, Madison.

Completed
Registry status
NA
Development phase
6
Enrollment target

NCT05689541: Completed NA study, sponsored by University of Wisconsin, Madison.

NCT05689541 is a NA study that has completed, run by University of Wisconsin, Madison. The registered enrollment target is 6 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (100% lower). According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT05689541, a NA study, has completed, sponsored by University of Wisconsin, Madison.

COMPLETED
Registry status
NA
Development phase
6 participants
Enrollment target

Study Summary

The purpose of this exploratory sequential mixed methods study is to develop and refine a parent-mediated mobile app intervention focused on improving the motor outcomes of children with autism spectrum disorder (ASD) participating in an adapted horseback riding program.

Primary Outcome

The Primary Outcome is to develop a mobile app using qualitative data collected through focus group discussions with therapeutic riding instructors and individual parent interviews; guided by the technology acceptance model. The technology acceptance model is comprised of four constructs: perceived ease of use, perceived usefulness, attitudes, and actual behaviors. Accordingly, the interview and focus group questions will focus on gaining feedback on aspects such as the user interface, time comm

Interventions

  • OTHER Mobile app intervention

Trial Details

FieldValue
Enrollment Target 6 participants
Start Date 2022-08-08
Est. Completion 2023-04-19
Phase NA
University of Wisconsin, Madison

1,039 total trials

What the finished NCT05689541 record still lists

NCT05689541 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 6 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (100% lower).

The record links to 0 conditions, and to 1 intervention - of which Mobile app intervention is the first listed.

NCT05689541 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT05689541 about?

NCT05689541 is a clinical study titled "Development of a Parent-mediated Mobile App Intervention for Parents of Children With Autism Spectrum Disorder Participating in an Adapted Horseback Riding Program". The purpose of this exploratory sequential mixed methods study is to develop and refine a parent-mediated mobile app intervention focused on improving the motor outcomes of children with autism spectrum disorder (ASD) participating in an adapted horseback riding program.

What is the current status of trial NCT05689541?

This trial is currently completed. It is a NA study. The enrollment target is 6 participants. The study started on 2022-08-08. Estimated completion is 2023-04-19.

What interventions are being tested in trial NCT05689541?

The interventions under investigation include: Mobile app intervention (OTHER).

Who is sponsoring clinical trial NCT05689541?

This trial is sponsored by University of Wisconsin, Madison, which has 1,039 total clinical trials registered on ClinicalTrials.gov.

How this trial's enrollment target compares

Where NCT05689541's enrollment target sits among peer trials

6 1983rd of 2000 higher than 13 of 2,000 other NA trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT05689541, the US trial registry maintained by the National Library of Medicine. NCT05689541 (small enrollment · none site footprint · completed) retrieved and formatted by PlainTrial, see methodology.